Suppr超能文献

使用微量悬浮试验、比色法刃天青微板法和戴伊-恩格利中和剂法测定聚维酮碘对[具体微生物名称缺失]的最低抑菌浓度(MIC)和接触时间。

Determination of Minimum Inhibitory Concentration (MIC) and Contact Time of Povidone-Iodine against and Using Micro Suspension Test, Colorimetric Resazurin Microplate Assay, and Dey Engley Neutralizer Assay.

作者信息

Lacuna Azita Racquel G, Dato Micaella C, Loterio Loisse Mikaela M, Dayrit Geraldine B, Villanueva Sharon Yvette Angelina M, Lota Maria Margarita M

机构信息

Department of Medical Microbiology, College of Public Health, University of the Philippines Manila.

出版信息

Acta Med Philipp. 2025 Mar 31;59(4):113-124. doi: 10.47895/amp.v59i4.10222. eCollection 2025.

Abstract

BACKGROUND AND OBJECTIVE

The human nasal passages host major human pathogens. Recent research suggests that the microbial communities inhabiting the epithelial surfaces of the nasal passages play a key factor in maintaining a healthy microenvironment by affecting both resistance to pathogens and immunological responses. Colonization of the nasal cavity by different pathogens such as and , is associated with a higher postoperative infection morbidity. Povidone-iodine (PVP-I) as an antiseptic has been proven to display high antibacterial, antiviral, and antifungal properties even at low concentrations, and was shown to be effective in the control of infections to limit their impact and spread. It can be used as a topical antiseptic for skin decontamination and wound management, as a nasal spray, or as a gargle. There are different methods in testing the efficacy of potential antimicrobial suspensions. This study aimed to determine the concentration of PVP-I that is most effective in nasal decolonization using microsuspension test and colorimetric minimum inhibitory concentration (MIC) determination assays, resazurin microtiter assay (REMA), and Dey-Engley (D/E) neutralizer assay. The findings of this study will contribute to knowledge regarding the intended use of PVP-I in microbial control, particularly in bacterial infections.

METHODS

Several dilutions (2.0%, 1.0%, 0.5%, 0.25%, 0.1% and 0.09%) of commercially bought 10% (10 mg per 100 ml) povidone-iodine were prepared and tested against a standardized inoculum (1x10) of at different contact times (5 seconds, 10 seconds, 30 seconds, 1 minute, and 5 minutes). Microdilution suspension test was performed to determine the log reduction per variable, while REMA and D/E neutralizer assay were used to determine the MIC. A value of greater than or equal to 5 log reduction was considered effective for microdilution suspension test. Estimates of agreement statistics were used to interpret the results of the assay in which the overall percent agreement (OPA), positive percent agreement (PPA), negative percent agreement (NPA), and Cohen's kappa statistics were calculated.

RESULTS

Povidone-iodine concentration of 0.25% exhibited ≥5 log reduction against at the minimum contact time of 5 seconds. On the other hand, a slightly higher PVP-I concentration was required to achieve ≥5 log reduction for at 0.5% concentration and a minimum contact time of 1 minute. There was an observed concordance of the results of REMA and D/E neutralizer as MIC colorimetric indicators, which yielded an overall test percent agreement of 90.30% (95% CI: 84.73-94.36), and a strong level of agreement (Κ = 0.8, <0.0001). A lower overall percent agreement for both REMA and D/E neutralizer versus the microsuspension test was observed at 79.17% (Κ = 0.57, <0.0001) and 78.18% (Κ = 0.55, <0.0001), respectively.

CONCLUSION

Low povidone-iodine concentrations (i.e., 0.5% against and 0.25% against ) were observed to have bactericidal activity of at least 5 log reduction as rapid as the minimum contact time of 5 seconds. Furthermore, D/E and REMA, as colorimetric indicators, had comparable performance (OPA = 90.30%; Κ = 0.8, <0.0001) suggesting that both REMA and D/E neutralizer assay may detect the same range of minimum inhibitory concentration for the organisms and disinfectant tested in this study.

摘要

背景与目的

人类鼻腔中存在主要的人类病原体。近期研究表明,栖息于鼻腔上皮表面的微生物群落通过影响对病原体的抵抗力和免疫反应,在维持健康微环境中起着关键作用。不同病原体如[具体病原体1]和[具体病原体2]在鼻腔的定植与较高的术后感染发病率相关。聚维酮碘(PVP - I)作为一种防腐剂,已被证明即使在低浓度下也具有高抗菌、抗病毒和抗真菌特性,并被证明在控制感染以限制其影响和传播方面是有效的。它可用作皮肤去污和伤口处理的局部防腐剂、鼻腔喷雾剂或漱口水。在测试潜在抗菌悬浮液的功效方面有不同的方法。本研究旨在使用微悬浮试验、比色最低抑菌浓度(MIC)测定法、刃天青微量滴定法(REMA)和戴伊 - 恩格利(D/E)中和剂测定法,确定在鼻腔去定植中最有效的聚维酮碘浓度。本研究的结果将有助于了解聚维酮碘在微生物控制,特别是细菌感染中的预期用途。

方法

制备市售10%(每100 ml含10 mg)聚维酮碘的几种稀释液(2.0%、1.0%、0.5%、0.25%、0.1%和0.09%),并在不同接触时间(5秒、10秒、30秒、1分钟和5分钟)针对标准化接种物(1×10)[具体细菌]进行测试。进行微量稀释悬浮试验以确定每个变量的对数减少量,而使用REMA和D/E中和剂测定法来确定MIC。对于微量稀释悬浮试验,大于或等于5对数减少的值被认为是有效的。使用一致性统计估计来解释试验结果,其中计算了总体一致百分比(OPA)、阳性一致百分比(PPA)、阴性一致百分比(NPA)和科恩kappa统计量。

结果

0.25%的聚维酮碘浓度在最短接触时间5秒时对[具体细菌]表现出≥5对数减少。另一方面,对于[另一种具体细菌],在0.5%浓度和最短接触时间1分钟时需要略高的聚维酮碘浓度才能实现≥5对数减少。观察到REMA和D/E中和剂作为MIC比色指标的结果具有一致性,总体试验一致百分比为90.30%(95% CI:84.73 - 94.36),并且一致性水平很强(Κ = 0.8,<0.0001)。与微量悬浮试验相比,REMA和D/E中和剂的总体一致百分比分别较低,为79.17%(Κ = 0.57,<0.0001)和78.18%(Κ = 0.55,<0.0001)。

结论

观察到低聚维酮碘浓度(即针对[具体细菌1]为0.5%,针对[具体细菌2]为0.25%)具有至少5对数减少的杀菌活性,速度快至最短接触时间5秒。此外,作为比色指标,D/E和REMA具有可比的性能(OPA = 90.30%;Κ = 0.8,<0.0001),这表明REMA和D/E中和剂测定法可能检测到本研究中测试的生物体和消毒剂的相同范围的最低抑菌浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/12037336/755402bbe0b0/AMP-59-4-10222-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验